Literature DB >> 14763679

Ethics in psychiatric research: study design issues.

Gordon DuVal1.   

Abstract

OBJECTIVE: To identify and discuss ethical aspects of study design issues in psychiatric research.
METHOD: We conducted a literature review and conceptual analysis of study design in psychiatric research focusing on placebo, medication tapering and withdrawal (washout), and symptom provocation (challenge) designs.
RESULTS: While advances in the care and treatment of persons with psychiatric disorders are crucial to the improved well-being of this stigmatized and often forgotten population, past abuses demonstrate the importance of the thoughtful application of ethical principles in the conduct of research. Some ethical issues have particular relevance to psychiatric research arising primarily from the specific vulnerabilities of those with mental illness and the risks posed by some research methodologies. Accordingly, sensitivity is required in the design of psychiatric research.
CONCLUSION: Placebo, challenge, and washout study designs can present particular risks in the population of persons with mental illness. These issues are described and suggestions offered to promote the ethical design of psychiatric research.

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Year:  2004        PMID: 14763679     DOI: 10.1177/070674370404900109

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  8 in total

1.  The Ethics of Clinical Trials Research in Severe Mood Disorders.

Authors:  Allison C Nugent; Franklin G Miller; Ioline D Henter; Carlos A Zarate
Journal:  Bioethics       Date:  2017-05-15       Impact factor: 1.898

2.  Factors Influencing Perceived Helpfulness and Participation in Innovative Research: A Pilot Study of Individuals with and without Mood Symptoms.

Authors:  Jane Paik Kim; Tenzin Tsungmey; Maryam Rostami; Sangeeta Mondal; Max Kasun; Laura Weiss Roberts
Journal:  Ethics Behav       Date:  2021-09-22

3.  Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.

Authors:  Allison C Nugent; Nicolas D Iadarola; Frank G Miller; David A Luckenbaugh; Carlos A Zarate
Journal:  Lancet Psychiatry       Date:  2016-03-10       Impact factor: 27.083

4.  The need for additional safeguards in the informed consent process in schizophrenia research.

Authors:  K K Anderson; S D Mukherjee
Journal:  J Med Ethics       Date:  2007-11       Impact factor: 2.903

Review 5.  Research governance: regulating risk and reducing harm?

Authors:  Sara Shaw; Geraldine Barrett
Journal:  J R Soc Med       Date:  2006-01       Impact factor: 18.000

6.  Challenges in conducting psychiatry studies in India.

Authors:  Saifuddin Kharawala; Jeroze Dalal
Journal:  Perspect Clin Res       Date:  2011-01

7.  Informed consent in psychiatry clinical research: A conceptual review of issues, challenges, and recommendations.

Authors:  Umesh Chandra Gupta; Saifuddin Kharawala
Journal:  Perspect Clin Res       Date:  2012-01

8.  Complexity changes in functional state dynamics suggest focal connectivity reductions.

Authors:  David Sutherland Blair; Carles Soriano-Mas; Joana Cabral; Pedro Moreira; Pedro Morgado; Gustavo Deco
Journal:  Front Hum Neurosci       Date:  2022-09-23       Impact factor: 3.473

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.